Hematologic Malignancies

MO 23 - Hematologic 3

Moderator(s)

• BD

  Bouthaina Dabaja, MD

  MD Anderson Cancer Center
• LB

  Leslie Ballas, MD

  University of Southern California Keck School of Medicine

Presentations:

• 2:45 PM - 2:50 PM

  Improved Overall Survival in CNS Lymphoma Patients Treated with Concurrent Temozolomide and Radiation
  Presenter: Anna Laucis, MD, MPhil – University of Michigan
  Presentation No : 1278
• 2:50 PM - 2:55 PM

  Simultaneous Integrated Boost IMRT with Three Dose Gradients in Patients with Stage I-II Nasal Cavity and Waldeyer's Ring Natural Killer/T-Cell Lymphoma: A Prospective Phase II Clinical Trial
  Presenter: Yujing Zhang, MD, PhD – Sun Yat-Sen University Cancer Center
  Presentation No : 1279
• 2:55 PM - 3:00 PM

  An International Systematic Review and Meta-Analysis of Dose Response for Cutaneous T-Cell Lymphoma Treated with Total Skin Electron Beam Therapy
  Presenter: Andrew Song, MD – Thomas Jefferson University
  Presentation No : 1280
• 3:00 PM - 3:05 PM

  Quality of Life Improvement Following Low-Dose Total Skin Electron Beam Therapy in Patients with Mycosis Fungoides or Sezary Syndrome
  Presenter: Khaled Elsayad, MD – University Hospital of Muenster
  Presentation No : 1281
• 3:05 PM - 3:10 PM

  Total Body Irradiation - Comparison of Outcome After Various Techniques of Irradiation and Shielding: A Polish Lymphoma Research Group (PLRG) Multicenter Study
  Presenter: Slawomir Blamek, MD, PhD – Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
  Presentation No : 1282
• 3:10 PM - 3:15 PM

  Dosimetric Lung Constraints and Neutrophil-Lymphocyte Ratio as Predictors of Radiation Pneumonitis in Lymphoma Patients treated with Mediastinal IMRT
  Presenter: Sonal Noticewala, MD, MS, BA – MD Anderson Cancer Center
  Presentation No : 1283
• 3:15 PM - 3:20 PM

  Prospective Evaluation of Total Body Radiation in the Conditioning Regimen of Patients Undergoing Allogeneic Stem Cell Transplantation for Sickle Cell Disease
  Presenter: Matthew Koshy, MD – Unviersity of Chicago
  Presentation No : 1284
• 3:20 PM - 3:25 PM

  Adverse Effects of Total Body Irradiation: A Single Institution Analysis
  Presenter: Renee Hanna, BS – Michigan State University College of Osteopathic Medicine
  Presentation No : 1285
• 3:25 PM - 3:30 PM

  Treatment Benefit Associating with Non-Anthracycline Chemotherapy in Extranodal NK/T-Cell Lymphoma, Nasal Type: A Multicenter Study from the China Lymphoma Collaborative Group (CLCG)
  Presenter: Yong Yang, MD – Cancer Institute & Hospital Chinese Acedemy of Medical Sciences
  Presentation No : 1286
• 3:30 PM - 3:35 PM

  Patient Survival With and Without Radiotherapy for Early Stage Diffuse Large B-Cell Lymphoma in the Era of PET and Rituximab
  Presenter: Christopher McLaughlin, MD – VCU Massey Cancer Center
  Presentation No : 1287
• 3:35 PM - 3:40 PM

  Impact of Cell of Origin, MYC/BCL2 Dual Expression and MYC Rearrangements in Diffuse Large B-Cell Lymphoma Patients Treated with Combined Modality Therapy
  Presenter: Chelsea Pinnix, MD, PhD – MD Anderson Cancer Center
  Presentation No : 1288
• 3:40 PM - 3:45 PM

  Outcomes Following Involved Node Radiation Therapy for Early Stage Diffuse Large B-Cell Lymphoma
  Presenter: Maja Maraldo, MD, PhD – Rigshospitalet
  Presentation No : 1289
• 3:45 PM - 3:50 PM

  Bi-Institutional Analysis of Stage III/IV Diffuse Large B Cell Lymphomas (DLBCL) Patients Undergoing Consolidative Radiotherapy: Potential for Improved Overall Survival (OS) and Progression Free Survival (PFS)
  Presenter: Yusef Syed, MD, BS, MEng – Emory University
  Presentation No : 1290
• 3:50 PM - 3:55 PM

  Accelerated Fractionated Compared to Conventional Fractionated Salvage Radiation Therapy Improves Outcomes in Salvage Chemotherapy Refractory Diffuse Large B-Cell Lymphoma
  Presenter: Brendan Coutu, MD – University of Nebraska Medical Center
  Presentation No : 1291
• 3:55 PM - 4:00 PM

  Discussant
  Discussant: Christopher Kelsey, MD – Duke University Medical Center